Zacks Investment Research on MSN

Vertex Pharmaceuticals Incorporated (VRTX) is attracting investor attention: Here is what you should know

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Business Insider

Vertex: Strong Q3 Performance and Strategic Initiatives Bolster Buy Rating

William Blair analyst Jake Roberge has maintained their bullish stance on VERX stock, giving a Buy rating today. Jake Roberge has given his Buy rating due to a combination of factors including ...
Business Insider

Neutral Hold Rating on Vertex Amidst Mixed Q2 Performance and Strategic Acquisition

Bradley Sills, an analyst from Bank of America Securities, reiterated the Hold rating on Vertex (VERX – Research Report). The associated price target was raised to $40.00. Bradley Sills has given his ...

Vertex Pharmaceuticals: The Cost Of Growing Beyond Cystic Fibrosis (Rating Downgrade)

Vertex Pharmaceuticals is anchored by cystic fibrosis as launches lag, JOURNAVX and CASGEVY add little revenue, and growth is ...
pv magazine International

Experts underline quality, reliability and performance of Vertex N modules

In the webinar organized by pv magazine, the representatives talked of the quality, reliability and performance of Trina Solar’s Vertex N modules. These modules have passed numerous extended ...